
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Oncology, Markers, Clinical Correlates |
1 Department of Cell Biology, 2 Department of Medicine, Division of Hematology/Oncology, 3 Department of Pathology, 4 Department of Surgery, and 5 Department of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Birmingham, Alabama
Purpose: The Krüppel-like transcription factor KLF4/GKLF induces both malignant transformation and a slow-growth phenotype in vitro. Although KLF4 expression is increased in most cases of breast cancer, it was unknown whether these cases represent a distinct subtype with a different clinical outcome.
Experimental Design: We examined expression of KLF4 by immunostaining 146 cases of human primary infiltrating ductal carcinoma of the breast. Staining patterns were correlated with clinical outcome and with established prognostic factors.
Results: Subcellular localization exhibited case-to-case variation. Tumors with high nuclear staining and low cytoplasmic staining were termed type 1. For patients with early-stage disease (i.e., stage I or IIA), type 1 staining was associated with eventual death because of breast cancer (hazard ratio, 2.8; 95% confidence interval, 1.236.58; P = 0.011). The association was stronger in patients with early-stage cancer and small primary tumors (i.e.,
2.0 cm in diameter; hazard ratio, 4.3; 95% confidence interval, 1.7510.62; P < 0.001). For patients with early-stage disease, multivariate analysis indicated that type 1 staining was independently associated with outcome (adjusted hazard ratio 2.6; 95% confidence interval, 1.106.05; P = 0.029). Type 1 staining was also associated with high histological grade (P = 0.032), increased expression of Ki67 (P = 0.016), and reduced expression of BCL2 (P = 0.032). In vitro, KLF4 was localized within the nucleus of transformed RK3E epithelial cells, consistent with a nuclear function of this transcription factor during induction of malignant transformation.
Conclusions: The results suggest that localization of KLF4 in the nucleus of breast cancer cells is a prognostic factor and identify KLF4 as a marker of an aggressive phenotype in early-stage infiltrating ductal carcinoma.
This article has been cited by other articles:
![]() |
P. M. Evans, W. Zhang, X. Chen, J. Yang, K. K. Bhakat, and C. Liu Kruppel-like Factor 4 Is Acetylated by p300 and Regulates Gene Transcription via Modulation of Histone Acetylation J. Biol. Chem., November 23, 2007; 282(47): 33994 - 34002. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Behr, C. Deller, M. Godmann, T. Muller, M. Bergmann, R. Ivell, and K. Steger Kruppel-like factor 4 expression in normal and pathological human testes Mol. Hum. Reprod., November 1, 2007; 13(11): 815 - 820. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wei, H. Xu, and D. Kufe Human Mucin 1 Oncoprotein Represses Transcription of the p53 Tumor Suppressor Gene Cancer Res., February 15, 2007; 67(4): 1853 - 1858. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Suh, J. M. Crutchley, A. Koochek, A. Ryscavage, K. Bhat, T. Tanaka, A. Oshima, P. Fitzgerald, and S. H. Yuspa Reciprocal Modifications of CLIC4 in Tumor Epithelium and Stroma Mark Malignant Progression of Multiple Human Cancers Clin. Cancer Res., January 1, 2007; 13(1): 121 - 131. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Wei, M. Kanai, S. Huang, and K. Xie Emerging role of KLF4 in human gastrointestinal cancer Carcinogenesis, January 1, 2006; 27(1): 23 - 31. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Graham, M. L. Yager, H. D. Hill, K. Byth, G. M. O'Neill, and C. L. Clarke Altered Progesterone Receptor Isoform Expression Remodels Progestin Responsiveness of Breast Cancer Cells Mol. Endocrinol., November 1, 2005; 19(11): 2713 - 2735. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Li, J. McClintick, L. Zhong, H. J. Edenberg, M. C. Yoder, and R. J. Chan Murine embryonic stem cell differentiation is promoted by SOCS-3 and inhibited by the zinc finger transcription factor Klf4 Blood, January 15, 2005; 105(2): 635 - 637. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |